期刊
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
卷 1792, 期 12, 页码 1097-1102出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.bbadis.2009.03.002
关键词
mtDNA; Mitochondria; Genetic bottleneck; Inheritance
资金
- Ataxia (UK)
- Parkinson's disease Society (UK)
- Medical Research Council (UK)
- UK NIHR Biomedical Research Centre
Mitochondrial DNA mutations cause disease in > 1 in 5000 of the population, and similar to 1 in 200 of the population are asymptomatic carriers of a pathogenic mtDNA mutation. Many patients with these pathogenic mtDNA mutations present with a progressive, disabling neurological syndrome that leads to major disability and premature death. There is currently no effective treatment for mitochondrial disorders, placing great emphasis on preventing the transmission of these diseases. An empiric approach can be used to guide genetic counseling for common mtDNA mutations, but many families transmit rare or unique molecular defects. There is therefore a pressing need to develop techniques to prevent transmission based on a solid understanding of the biological mechanisms. Several recent studies have cast new light on the genetics and cell biology of mtDNA inheritance, but these studies have also raised new controversies. Here we compare and contrast these findings and discuss their relevance for the transmission of human mtDNA diseases. (C) 2009 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据